A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients
How to cite: Paparella, G.; Stragà, C.; Pesenti, N.; Dal Molin, V.; Martorel, G. A.; Merotto, V.; Genova, C.; Piazza, A.; Piccoli, G.; Panzeri, E.; Rufini, A.; Testi, R.; Martinuzzi, A. A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients. Preprints 2024, 2024021303. https://doi.org/10.20944/preprints202402.1303.v1 Paparella, G.; Stragà, C.; Pesenti, N.; Dal Molin, V.; Martorel, G. A.; Merotto, V.; Genova, C.; Piazza, A.; Piccoli, G.; Panzeri, E.; Rufini, A.; Testi, R.; Martinuzzi, A. A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients. Preprints 2024, 2024021303. https://doi.org/10.20944/preprints202402.1303.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)